Rossari Biotech Limited

Informe acción NSEI:ROSSARI

Capitalización de mercado: ₹46.1b

Salud financiera de hoja de balance de Rossari Biotech

Salud financiera controles de criterios 6/6

Rossari Biotech tiene un patrimonio de accionistas total de ₹11.2B y una deuda total de ₹1.4B, lo que sitúa su ratio deuda-patrimonio en 12.8%. Sus activos y pasivos totales son ₹17.1B y ₹5.9B respectivamente. El BAIT de Rossari Biotech es de ₹1.9B, por lo que su ratio de cobertura de intereses es de 14.5. Tiene efectivo e inversiones a corto plazo que ascienden a ₹800.1M.

Información clave

12.8%

Ratio deuda-patrimonio

₹1.43b

Deuda

Ratio de cobertura de intereses14.5x
Efectivo₹800.08m
Patrimonio₹11.18b
Total pasivo₹5.93b
Activos totales₹17.11b

Actualizaciones recientes sobre salud financiera

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹9.4B) de ROSSARI superan a sus pasivos a corto plazo (₹4.5B).

Pasivo a largo plazo: Los activos a corto plazo de ROSSARI (₹9.4B) superan a sus pasivos a largo plazo (₹1.4B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (5.6%) de ROSSARI se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de ROSSARI ha pasado de 17.4% a 12.8% en los últimos 5 años.

Cobertura de la deuda: La deuda de ROSSARI está bien cubierta por el flujo de caja operativo (81.3%).

Cobertura de intereses: Los pagos de intereses de la deuda de ROSSARI están bien cubiertos por el BAIT (14.5x cobertura).


Hoja de balance


Descubre empresas con salud financiera